Substrate delivery as a determinant of hepatic apoB secretion

scientific article

Substrate delivery as a determinant of hepatic apoB secretion is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.13.5.629
P698PubMed publication ID8485114

P50authorKatherine CianfloneQ66764527
Allan D SnidermanQ91894181
P433issue5
P304page(s)629-636
P577publication date1993-05-01
P1433published inArteriosclerosis and thrombosis : a journal of vascular biologyQ27709770
P1476titleSubstrate delivery as a determinant of hepatic apoB secretion
P478volume13

Reverse relations

cites work (P2860)
Q28346400A role for smooth endoplasmic reticulum membrane cholesterol ester in determining the intracellular location and regulation of sterol-regulatory-element-binding protein-2
Q33746676Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion
Q35849439Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function
Q36509548Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations
Q33858526Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.
Q41874838Are we waking up to the effects of NEFA?
Q74012709Characterization and modulation of LP(a) in human hepatoma HEPG2 cells
Q42982452Characterization of the inhibitory effects of bile acids on very-low-density lipoprotein secretion by rat hepatocytes in primary culture
Q42518323Cholesterol esters regulate apoB48 secretion in CaCo2 cells
Q51567163Cholesterol synthesis is increased in mixed hyperlipidaemia.
Q37737551Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
Q73228450Different patterns of brisk walking are equally effective in decreasing postprandial lipaemia
Q34564452Differential effect of corn oil-based low trans structured fat on the plasma and hepatic lipid profile in an atherogenic mouse model: comparison to hydrogenated trans fat.
Q73934655Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man
Q71965309Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects
Q47987252Divergent responses of the liver to increased delivery of glucose or fatty acids: implications for the pathogenesis of type IV hyperlipoproteinemia
Q37136074Dyslipidaemia in Adult Growth Hormone (GH) Deficiency and the Effect of GH Replacement Therapy: A Review
Q33756050Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice
Q30428195Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure
Q54147254Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation.
Q48787738Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.
Q33908606Exercise and dietary-mediated reductions in postprandial lipemia.
Q34223452Extended-release niacin acutely suppresses postprandial triglyceridemia
Q40802354Familial lipoprotein disorders and premature coronary artery disease.
Q44279291Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men.
Q35395461Fetal macrosomia related to maternal poorly controlled type 1 diabetes strongly impairs serum lipoprotein concentrations and composition
Q77452737Genetics of lipoprotein disorders
Q35919242Hepatic regulation of apolipoprotein B.
Q37354550Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet
Q54075056Impaired postprandial tissue regulation of blood flow in insulin resistance: a determinant of cardiovascular risk?
Q35137720Inflammation in sleep apnea: an update.
Q42166736Influence of simvastatin on apoB-100 secretion in non-obese subjects with mild hypercholesterolemia.
Q77135898Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol
Q35212552Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia
Q35754362Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies
Q36093354Metabolic dysfunction in obstructive sleep apnea: A critical examination of underlying mechanisms
Q27863447Microsomal triglyceride transfer protein
Q34504405NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases apolipoprotein B-100 secretion from Hep G2 cells
Q34074263Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB)
Q73701461Phenotype expression in familial combined hyperlipidemia
Q42981221Phosphatidylcholine increases the secretion of triacylglycerol-rich lipoproteins by CaCo-2 cells
Q34499464Polymorphism of rs1044925 in the acyl-CoA:cholesterol acyltransferase-1 gene and serum lipid levels in the Guangxi Bai Ku Yao and Han populations
Q93178699Population-Level Analysis to Determine Parameters That Drive Variation in the Plasma Metabolite Profiles
Q33746649Regulation of Plasma fatty acid metabolism
Q42274164Regulation of plasma LDL: the apoB paradigm
Q41004209Role of insulin in hepatic fatty acid partitioning: emerging concepts
Q33591459Role of the enterohepatic circulation of bile salts in lipoprotein metabolism
Q34121180Shifting the LDL-receptor paradigm in familial hypercholesterolemia: novel insights from recent kinetic studies of apolipoprotein B-100 metabolism
Q73409184Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes
Q71814893Simvastatin decreases the hepatic secretion of very‐low‐density lipoprotein apolipoprotein B‐100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications
Q28185968Structure of the human acyl-CoA:cholesterol acyltransferase-2 (ACAT-2) gene and its relation to dyslipidemia
Q41519599The acylation stimulating protein pathway: Clinical implications
Q24794764The effect of Puerariae radix on lipoprotein metabolism in liver and intestinal cells
Q77794967The influence of exercise on postprandial triacylglycerol metabolism
Q57420304The reduction in postprandial lipemia after exercise is independent of the relative contributions of fat and carbohydrate to energy metabolism during exercise
Q42538179Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Tr
Q73625943Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells

Search more.